Barclays PLC Opiant Pharmaceuticals, Inc. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 10, 2020
SELL
$13.16 - $15.96 $394 - $478
-30 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$11.26 - $16.48 $337 - $494
30 New
30 $0
Q2 2018

Aug 14, 2018
SELL
$14.31 - $20.59 $57 - $82
-4 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$18.8 - $26.5 $75 - $106
4 New
4 $0

Others Institutions Holding OPNT

# of Institutions
2
Shares Held
300
Call Options Held
0
Put Options Held
0
View Full List

About OPIANT PHARMACEUTICALS, INC.

OPNT Quotes by TradingView
  • Ticker OPNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,164,150
  • Description
  • Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...
More about OPNT
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email